Autolus Announces Pricing of Underwritten Offering
GlobeNewswire
LONDON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company..
LONDON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company..
MADISON, N.J.--(BUSINESS WIRE)--Transcend Capital Advisors today announced a name, image, and likeness (NIL) partnership with..
Suna Lee (Of Counsel-Madison, NJ) was granted a Motion to Dismiss this case in its entirety for lack of personal jurisdiction..